What is CellVax Therapeutics worth?
$52.5Mlast known valuation
CellVax Therapeutics last raised $2.1M in its Seed Round (Sep 2024).
Free account
See the evidence behind this price
- ·Post-money valuations for all 1 rounds
- ·Watchlist + deal alerts for CellVax Therapeutics
Create free account
No card required
Funding history
1 rounds| Date | Round | Raised | Post-money | $/share |
|---|---|---|---|---|
| Sep 2024 | Seed Round | $2.1M | ▮ | ▮ |
How CellVax Therapeutics's valuation is determined
Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.
For CellVax Therapeutics, too few pricing signals exist to publish a composite mark; the figures above reflect the most recent observed valuation event. Full methodology →
Frequently asked
- What is CellVax Therapeutics worth?
- CellVax Therapeutics's last known valuation is $52.5M.
- How much has CellVax Therapeutics raised?
- CellVax Therapeutics has raised $7.3M in total funding across 1 recorded rounds.
- When did CellVax Therapeutics last raise?
- CellVax Therapeutics last raised in Sep 2024 (Seed Round), raising $2.1M.